NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,761 | +15.1% | 27,108 | +14.0% | 0.65% | +17.4% |
Q2 2023 | $2,399 | +30.1% | 23,774 | +18.6% | 0.56% | +23.8% |
Q1 2023 | $1,844 | +12.5% | 20,044 | +11.0% | 0.45% | +4.4% |
Q4 2022 | $1,639 | -99.9% | 18,062 | +14.1% | 0.43% | +19.4% |
Q3 2022 | $1,203,000 | -15.0% | 15,830 | -5.4% | 0.36% | -13.2% |
Q2 2022 | $1,415,000 | -6.2% | 16,739 | -2.6% | 0.42% | -5.2% |
Q1 2022 | $1,509,000 | +48.2% | 17,194 | +47.8% | 0.44% | +33.0% |
Q4 2021 | $1,018,000 | +2382.9% | 11,633 | +2194.5% | 0.33% | +1220.0% |
Q3 2021 | $41,000 | +127.8% | 507 | +153.5% | 0.02% | +108.3% |
Q2 2021 | $18,000 | +5.9% | 200 | 0.0% | 0.01% | -7.7% |
Q1 2021 | $17,000 | -10.5% | 200 | 0.0% | 0.01% | -13.3% |
Q4 2020 | $19,000 | +11.8% | 200 | 0.0% | 0.02% | +7.1% |
Q3 2020 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $17,000 | +6.2% | 200 | 0.0% | 0.01% | -17.6% |
Q1 2020 | $16,000 | -15.8% | 200 | 0.0% | 0.02% | -56.4% |
Q4 2019 | $19,000 | +11.8% | 200 | 0.0% | 0.04% | +5.4% |
Q3 2019 | $17,000 | -5.6% | 200 | 0.0% | 0.04% | -15.9% |
Q2 2019 | $18,000 | -5.3% | 200 | 0.0% | 0.04% | -51.6% |
Q1 2019 | $19,000 | – | 200 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |